09th week of 2019 patent applcation highlights part 32 |
Patent application number | Title | Published |
20190062308 | 1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME | 2019-02-28 |
20190062309 | 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF | 2019-02-28 |
20190062310 | TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF | 2019-02-28 |
20190062311 | QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KB INHIBITORS | 2019-02-28 |
20190062312 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | 2019-02-28 |
20190062313 | COVALENT INHIBITORS OF KRAS | 2019-02-28 |
20190062314 | COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER | 2019-02-28 |
20190062315 | PYRIDONE DERIVATIVE COMPRISING HETEROATOMIC RING BUTANE SUBSTITUENT, FOR TREATING FIBROSIS AND INFLAMMATORY DISEASES | 2019-02-28 |
20190062316 | PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES | 2019-02-28 |
20190062317 | COMPOUNDS | 2019-02-28 |
20190062318 | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS | 2019-02-28 |
20190062319 | Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders | 2019-02-28 |
20190062320 | ETHER COMPOUNDS AND USES THEREOF | 2019-02-28 |
20190062321 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | 2019-02-28 |
20190062322 | PUMA INHIBITOR, METHOD FOR PREPARATION THEREOF, AND USE THEREOF | 2019-02-28 |
20190062323 | PI-Kinase Inhibitors with Anti-Infective Activity | 2019-02-28 |
20190062324 | AUTOTAXIN INHIBITORS | 2019-02-28 |
20190062325 | NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | 2019-02-28 |
20190062326 | 2-PHENYL-3-(PIPERAZINOMETHYL)IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS BLOCKERS OF TASK-1 AND TASK-2 CHANNELS, FOR THE TREATMENT OF SLEEP-RELATED BREATHING DISORDERS | 2019-02-28 |
20190062327 | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS | 2019-02-28 |
20190062328 | BRUTON'S TYROSINE KINASE INHIBITORS | 2019-02-28 |
20190062329 | ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF | 2019-02-28 |
20190062330 | KRAS G12C INHIBITORS | 2019-02-28 |
20190062331 | 6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDIN-5-ONE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | 2019-02-28 |
20190062332 | PROCESS FOR THE PREPARATION OF LEDIPASVIR AND INTERMEDIATES THEREOF | 2019-02-28 |
20190062333 | CXCR4 RECEPTOR ANTAGONISTS | 2019-02-28 |
20190062334 | ORGANIC COMPOUNDS | 2019-02-28 |
20190062335 | IMIDAZOPYRAZINONES AS PDE1 INHIBITORS | 2019-02-28 |
20190062336 | HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS | 2019-02-28 |
20190062337 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF {1-(ETHYLSULFONYL)-3-[4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL- ]AZETIDIN-3-YL}ACETONITRILE | 2019-02-28 |
20190062338 | TRICYCLIC COMPOUND SERVING AS IMMUNOMODULATOR | 2019-02-28 |
20190062339 | HEMI-SYNTHETIC TRILOBINE ANALOGS FOR USE AS A DRUG | 2019-02-28 |
20190062340 | CORTISTATIN ANALOGS | 2019-02-28 |
20190062341 | TRICYCLIC COMPOUNDS HAVING ANTIMITOTIC AND/OR ANTITUMOR ACTIVITY AND METHODS OF USE THEREOF | 2019-02-28 |
20190062342 | NOVEL ANTIBACTERIAL AGENTS | 2019-02-28 |
20190062343 | DIAMIDE MACROCYCLES HAVING FACTOR XIA INHIBITING ACTIVITY | 2019-02-28 |
20190062344 | CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES | 2019-02-28 |
20190062345 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2019-02-28 |
20190062346 | Method for Producing 7h-pyrrolo[2, 3-d]pyrimidine Derivative and Intermediate Thereof | 2019-02-28 |
20190062347 | METHOD FOR PRODUCING METAL ORGANYLS | 2019-02-28 |
20190062348 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | 2019-02-28 |
20190062349 | COMPOUND FOR SPECIFICALLY BINDING TO AMYLOID B-PROTEIN | 2019-02-28 |
20190062350 | METHODS FOR PRODUCING BORYLATED ARENES | 2019-02-28 |
20190062351 | CHARGE-TRANSPORTING VARNISH | 2019-02-28 |
20190062352 | SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY | 2019-02-28 |
20190062353 | SUBSTITUTED DIHYDROPYRROLOPYRAZOLE COMPOUND | 2019-02-28 |
20190062354 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | 2019-02-28 |
20190062355 | IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES | 2019-02-28 |
20190062356 | PH RESPONSIVE FLUORESCENT COMPOUND, COMPOSITION FOR DETECTING MITOPHAGY USING SAME, AND METHOD FOR DETECTING MITOPHAGY WITHIN CELLS | 2019-02-28 |
20190062357 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ORGANIC LIGHT-EMITTING APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | 2019-02-28 |
20190062358 | PRECIOUS METAL COMPOUNDS | 2019-02-28 |
20190062359 | ORGANOSOLV PROCESS FOR THE EXTRACTION OF HIGHLY PURE LIGNIN AND PRODUCTS COMPRISING THE SAME | 2019-02-28 |
20190062360 | PROCESS FOR PREPARING COMPOSITIONS COMPRISING ALKYL(ALKYL-GLUCOSIDE)URONATES, SAID COMPOSITIONS AND USE THEREOF AS A SURFACTANT | 2019-02-28 |
20190062361 | REGIOSELECTIVE SILYL EXCHANGE OF PER-SILYLATED OLIGOSACCHARIDES | 2019-02-28 |
20190062362 | METHOD FOR OBTAINING SURFACTANT COMPOSITIONS MADE FROM ALKYL-L-GULURONAMIDES | 2019-02-28 |
20190062363 | PREPARATION OF (S,S)-SECOISOLARICIRESINOL DIGLUCOSIDE AND (R,R)-SECOISOLARICIRESINOL DIGLUCOSIDE | 2019-02-28 |
20190062364 | PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS | 2019-02-28 |
20190062365 | COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE"-DEPENDENT SIGNALLING | 2019-02-28 |
20190062366 | Compositions and Methods For Fractal Assembly Of Micron-Scale Nucleic Acid Structures | 2019-02-28 |
20190062367 | METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF | 2019-02-28 |
20190062368 | POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS | 2019-02-28 |
20190062369 | LIGAND FUNCTIONAL SUBSTRATES | 2019-02-28 |
20190062370 | METHOD OF PURIFYING ANTIFUNGAL COMPOUNDS AND EXOPOLYSACCHARIDES FROM A MICROBIAL CELL CULTURE | 2019-02-28 |
20190062371 | PEPTIDE COMPOSITIONS AND RELATED METHODS | 2019-02-28 |
20190062372 | METHODS OF TREATING DEPRESSION AND OTHER RELATED DISEASES | 2019-02-28 |
20190062373 | METHOD OF GENERATING INTERACTING PEPTIDES | 2019-02-28 |
20190062374 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | 2019-02-28 |
20190062375 | COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT | 2019-02-28 |
20190062376 | Treatments for Gastrointestinal Disorders | 2019-02-28 |
20190062377 | PEPTIDOMIMETIC MACROCYCLES | 2019-02-28 |
20190062378 | CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS | 2019-02-28 |
20190062379 | Mutant of L1 Protein of Human Papillomavirus Type 11 | 2019-02-28 |
20190062380 | FUSION PROTEINS FOR PROMOTING AN IMMUNE RESPONSE, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF MAKING AND USE THEREOF | 2019-02-28 |
20190062381 | GENETICALLY ALTERED PLANTS HAVING WEEPING PHENOTYPE | 2019-02-28 |
20190062382 | INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE | 2019-02-28 |
20190062383 | Kv1.3 Antagonists and Methods of Use | 2019-02-28 |
20190062384 | NOVEL BT TOXIN RECEPTORS AND METHODS OF USE | 2019-02-28 |
20190062385 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS RELATED TO CEP290 | 2019-02-28 |
20190062386 | PEPTIDE INHIBITORS OF CALCIUM CHANNELS | 2019-02-28 |
20190062387 | METHOD FOR ESTABLISHING EUKARYOTIC EXPRESSION CELL LINE OF CD36 MUTANT GENE THAT ENCODES CD36 DEFICIENCY | 2019-02-28 |
20190062388 | COMPOSITIONS AND METHODS OF USING THERAPEUTIC p53 PEPTIDES AND ANALOGUES | 2019-02-28 |
20190062389 | PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS | 2019-02-28 |
20190062390 | Method for Producing An Active Hepatocyte Growth Factor (HGF) | 2019-02-28 |
20190062391 | USE OF VEGF-B FOR TREATING DISEASES INDUCED BY OXIDATIVE INJURY | 2019-02-28 |
20190062392 | METHODS FOR TREATING FATTY LIVER DISEASE | 2019-02-28 |
20190062393 | CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF | 2019-02-28 |
20190062394 | Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12 | 2019-02-28 |
20190062395 | IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES | 2019-02-28 |
20190062396 | COMPOSITION COMPRISING RECOMBINANT HUMAN THYROID STIMULATING HORMONE AND METHOD FOR PRODUCING RECOMBINANT HUMAN THYROID STIMULATING HORMONE | 2019-02-28 |
20190062397 | ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES | 2019-02-28 |
20190062398 | HIGH AVIDITY HPV T-CELL RECEPTORS | 2019-02-28 |
20190062399 | CARBOHYDRATE CONTENT OF CTLA4 MOLECULES | 2019-02-28 |
20190062400 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | 2019-02-28 |
20190062401 | Immunotherapy against melanoma and other cancers | 2019-02-28 |
20190062402 | ACVR1-FC FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 2019-02-28 |
20190062403 | PURIFICATION OF FACTOR VIII SUBSPECIES | 2019-02-28 |
20190062404 | Composition and Method for Therapeutic Agent Delivery During Pregnancy | 2019-02-28 |
20190062405 | REGENERATION OF DAMAGED TISSUE | 2019-02-28 |
20190062406 | METHODS OF USE OF SECRETORY IgA | 2019-02-28 |
20190062407 | AGENTS FOR INFLUENZA NEUTRALIZATION | 2019-02-28 |